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We demonstrated that a subterranean, visually blind mammal has a
functional set of three Per genes that are important components of
the circadian clockwork in mammals. The mole rat superspecies
Spalax ehrenbergi is a blind subterranean animal that lives its entire
life underground in darkness. It has degenerated eyes, but the retina
and highly hypertrophic harderian gland are involved in photoperi-
odic perception. All three Per genes oscillate with a periodicity of 24 h
in the suprachiasmatic nuclei, eye, and harderian gland and are
expressed in peripheral organs. This oscillation is maintained under
constant conditions. The light inducibility of sPer1 and sPer2, which
are similar in structure to those of other mammals, indicates the role
of these genes in clock resetting. However, sPer3 is unique in mam-
mals and has two truncated isoforms, and its expressional analysis
leaves its function unresolved. Per’s expression analysis in the hard-
erian gland suggests an important participation of this organ in the
stabilization and resetting mechanism of the central pacemaker in the
suprachiasmatic nuclei and in unique adaptation to life underground.
L ife on Earth is adapted to cyclical phenomena imposed by theexternal environment (1). Most organisms have circadian
systems that synchronize physiological events to the external
24-h cycle (2). The underlying molecular-genetic mechanisms of
these clocks exhibit an extraordinary evolutionary conservation
from cyanobacteria through plants, fruit f lies, and mammals. All
of these clock systems consist of autoregulatory transcriptional
translational feedback loops with positivenegative regulatory
elements and similar genetic machinery (3, 4).
Two basic helix–loop–helix PAS (PER-ARNT-SIM) tran-
scription factors, CLOCK and MOP3 (BMAL1), form the
positive elements of the system and drive transcription of three
Period (Per 1, 2, 3) and two Cryptochrome (Cry 1, 2) genes. The
protein products of these genes are thought to be components of
a negative feedback complex that inhibits the CLOCKMOP3
heterodimer, thereby closing the circadian loop.
The enigma of circadian rhythms in a blind subterranean
mammal is intriguing (5–7). We have already shown that a
CLOCKMOP3-driven clock exists in Spalax (8). Here we
continue to decipher its circadian machinery.
The Evolutionary Model of Blind Subterranean Mammals
The blind subterranean mammals, mole rats of the Spalax
ehrenbergi superspecies in Israel, consist of four species that have
been studied multidisciplinarily as an evolutionary model of
speciation and adaptation (5–7). Spalax lives in total darkness,
yet, it perceives the daily and seasonal temporal cycles under-
ground (9). Behaviorally, Spalax displays polyphasic and poly-
typic day-night activity patterns (10, 11) coupled with polymor-
phic (12) and seasonal variation, supported by a unique
photoperiodic perception mechanism (9). Spalax has a degen-
erated s.c. functional eye (13, 14), which, together with the
harderian gland, participates in photoperiodic perception (9,
15–18). The retina harbors Rhodopsin (19, 20) and Coneopsin
(21), adaptively effective in photoperiodic perception (22, 23),
and expresses alfa-B-crystallin (24). The photic signals entrain
c-fos in the suprachiasmatic nuclei (SCN) Zeitgeber (25) and can
possibly activate circadian genes.
Evolutionarily, Spalax’s perceptive brain structures (SCN and
striatum) were expanded and sight pathways were drastically
(90%) reduced. The visual cortex was replaced by somatosen-
sory cortex (26–28), Per homologous ACNGGN-repeats cycle in
the hypothalamus (29) and melatonin precursors occur in the
harderian and pineal glands and retina (30).
What is the genetic basis of circadian rhythmicity in Spalax?
We cloned, sequenced, and unraveled the expression of the
circadian Clock and MOP3 cDNAs of three species of the S.
ehrenbergi superspecies in Israel (8). Both genes are relatively
conserved, yet Clock displays a unique Q-rich area as compared
with other mammals, assumed to function in circadian rhyth-
micity, and Spalax CLOCKMOP3 dimer is less potent than its
human counterpart in driving transcription.
Here we describe the cloning, sequencing, and expression of
the three Period cDNAs of Spalax. Its three Per cDNAs are
conserved, yet they show features unique to Spalax especially in
Per3, Per1, and Per2 cycles in the SCN, eye, and harderian gland.
Per3 is structurally unique among studied sighted mammals and
awaits functional elucidation.
Materials and Methods
Animals. We analyzed adults (100–150 g), belonging to Spalax
judaei, (2n 60) from Anza, Samaria (7). Field-trapped animals
were kept at 22–24°C with seasonal photoperiod. We selected
diurnal animals that were kept under a 12-h light12-h dark
cycle. For analysis of Per transcriptional activity in constant
darkness, light was turned off at Zeitgeber time (ZT) 12, and
animals were kept in the dark for at least 2 days before being
killed under dim illumination (15-W safety red light). Light
inducibility experiments were done on animals kept in lightdark
for a week with a short light pulse (15 min,200 Lx) at specified
ZT followed by release into constant darkness. For gene induc-
tion analysis brains were taken 1 h after illumination. Each
experiment was done on three sets of animals.
Abbreviations: SCN, suprachiasmatic nuclei; ZT, Zeitgeber time; RT-PCR, reverse transcrip-
tion–PCR; ISH, in situ hybridization; CK1, casein kinase 1.
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Cloning of Spalax Per cDNAs. We cloned the three Spalax Per
cDNAs by reverse transcription–PCR (RT-PCR) (31). Oligos
were synthesized according to the ORF of the known human and
mouse homologous sequences (GenBank accession nos.
AF022991, AB002370, and AB047686 for human Per1, Per2, and
Per3, respectively and AF022992, AF036893, and AB013605 for
mouse Per1, Per2, and Per3, respectively). Whole brain total
RNA was prepared by using the TriReagent RNA isolation
reagent (Molecular Research Center, Cincinnati). First-strand
cDNA was synthesized with oligo(dT) as a primer and Super-
Script II reverse transcriptase enzyme (GIBCOBRL). This
cDNA product was taken for PCR by using TaqDNA polymerase
(Appligene, Strasbourg, France). The annealing temperature,
elongation time, and MgCl2 concentration were adjusted for
each specific PCR. In the case of sPer3 isolation, we verified our
RT-PCR results by also cloning through cDNA library screening
(32). Spalax brain cDNA library in Lambda-TripleEx was
screened by using a partial mPer3 cDNA as a probe. Sequencing
was determined by thermocycling sequencing using di-deoxy
nucleotide terminators (3700 DNA Analyzer, Perkin–Elmer
Applied Biosystems) at the sequencing unit of the Weizmann
Institute of Science (Rehovot, Israel).
Evolutionary Analysis. The evolutionary analysis of the Per cDNAs
presented here is based on distances and divergence calculations
(Wisconsin package version 10, GCG).
The DISTANCES program (33) calculates pairwise distances
between aligned sequences expressed as substitutions per 100
bases or amino acids. To correct the distances for multiple
substitutions at a site, we used Kimura’s nucleic acid (33) and
protein (34) methods.
The DIVERGE program estimates the pairwise number of
synonymous and nonsynonymous substitutions per site between
two or more coding aligned nucleic acid sequences (35, 36).
In Situ Hybridization (ISH). Tissues used for ISH were treated and
examined as described in Albrecht et al. (37). The Spalax Per1
probe corresponded to nucleotides 615-1300, the sPer2 probe
corresponded to nucleotides 85–605, and the probe of sPer3
corresponded to nucleotides 1751–2590.
Quantification was performed by densitometric analysis of hy-
bridization signals on x-ray films with Scion (Frederick, MD) IMAGE
4.0.2 software. For silver grain images, tissue was visualized by
fluorescence of Hoechst dye-stained nuclei, and silver grain signals
were artificially colored for clarity. Quantitation of ISH results was
analyzed with GraphPad (San Diego) PRISM software. Data sets
were compared by ANOVA with subsequent Bonferroni correc-
tion for multiple comparisons, with P  0.05 as the criterion of
significance.
Quantitative RT-PCR. For quantitation of the sPer genes expression
in the harderian gland and the liver of Spalax, a quantitative
RT-PCR was performed. Equal amounts of total RNA from
animals killed at the relevant ZT points were taken for first-
strand cDNA synthesis (see above). The cDNAs were synthe-
sized by adding equal traces of [32P]dCTP to ensure equal
amounts of cDNA templates in the PCRs. For the PCR we used
oligos synthesized according to the sequence of the different sPer
isolated clones. For each Per gene quantitation we used one
sense 5 oligo and two antisense 3 oligos (3[1] and 3[2]), giving
rise to two distinct products (450–600 bp). One set of oligos (5
and 3[1]) was used for the harderian gland and the other (oligos
5 and 3[2]) for the liver, in the same PCR tube. A second PCR
was carried out by changing the 3 oligo between the harderian
and liver tissues. In each PCR, a 300-bp fragment of actin, as an
internal control, was also synthesized, using specific actin oligos.
Each cDNA was first tested for different PCR amplification
cycles with the different sets of oligos. The final experimental
PCRs were performed at the logarithmic phase of the reaction
for each specific cDNA of interest (18–22 cycles). Each exper-
iment was carried out on two RNA samples taken from two
different individuals, and each PCR was repeated three times.
The PCR products were then run on ethidium bromide1.3%
agarose gels. The gels were subjected to quantitation of the
specific bands by the Eagle Eye II system (Stratagene). The
system integrates the density of the ethidium bromide of a
rectangle limiting a specific band in pixel values. The values
received for the specific Per bands were normalized according to
the values received for the actin bands (which were statistically
equal in the different tissues and in the different reactions).
Results
Cloning and Structural Analysis of the Three Spalax Per (sPer) Genes.
Analysis of the ORFs of Spalax Per cDNAs revealed transcripts
of 1,062 aa residues for sPER1 (GenBank accession no.
AJ345059) and 1,248 aa for sPER2 (GenBank accession no.
AJ345060). For sPER3 we isolated two truncated deduced
proteins, one with 489 aa (isoform a, GenBank accession no.
AJ345061) and the other with 583 aa (isoform b, GenBank
accession no. AJ345062). Identified functional domains like the
PAS domain and the basic helix–loop–helix motif are highly
similar in sPER1 and sPER2, but the homology in sPER3 is low.
The recently identified casein kinase 1 (CK1) binding site of
human PER2 and the five putative phosphorylation sites (AA
668, 671, 674, 677, and 680) (38) are conserved in PER proteins
of Spalax, mice, and humans with the exception of sPER3. Hence
sPER3 is probably not a substrate for the Spalax CK1 ortholog.
Evolutionary Analysis of the Spalax Per Genes. Protein trees of
PER1, PER2, and PER3 in Spalax, mice, rats, and humans
appear in Fig. 1. The Drosophila Per (GenBank accession no.
X03636) was also compared, but it was very different from the
three mammalian Per proteins. The computer program used
(GCG10) estimated the distance of the dPer from its mammalian
counterparts as maximal and beyond the accuracy of the method.
The estimated divergence time between Spalax and other
rodents is much shorter than the divergence between humans
and rodents. Therefore, we expected that the genetic distance
between Spalax and mice or rats would be considerably smaller
than between humans and these two rodents. We also expected
that the distance between humans and Spalax and between
humans and mice or rats would be similar. Any divergence from
these expectations can suggest that additional factor(s) influence
the rate of evolution of the Per genes of Spalax and, therefore,
deviate from the phylogenetic divergence time.
Below we present the evolutionary analysis for each Per gene
separately.
Per1. There is agreement between the above evolutionary
expectations and the PER1 proteins (Fig. 1 Top) and Per1
nucleotide sequence (tree not shown). The relative distances in
protein and nucleotides between Spalax and mice are 75% (6.85
vs. 9.12) and 80% (10.51 vs. 13.18) of the distances between
Spalax and humans, respectively. The distances between rodents
(Spalax and mice) and humans are similar: 9.12 and 8.04 in the
protein and 13.18 and 13.26 in the nucleotide sequence.
Per2. Rat PER2 (GenBank accession no. MN031678) was also
included and expected to be similar to mouse PER2. As in Per1,
PER2 results were in agreement with the phylogenetic expec-
tations (Fig. 1 Middle). The relative distances between Spalax
and mice were 42% (11.55 vs. 27.54) or 59% (13.07 vs. 22.09) of
the distances between Spalax and humans in protein and nucle-
otides, respectively. The distances between Spalax and rats were
46% (12.69 vs. 27.54) or 66% (14.6 vs. 22.09) of the distances
between Spalax and humans in protein and nucleotides, respec-
tively. The distances between rodents (mice, rats, and Spalax)







and humans were also similar: 27.00, 27.70, and 27.54 for protein
and 22.56, 23.58, and 22.09 for nucleotides, respectively.
Per3. As mentioned, we cloned two truncated clones of Spalax
Per3 (named a and b). Both clones start at the equivalent of
mouse 468 bp (110 bp 3 to the mouse ATG initiation codon).
We could not isolate any further 5 sequences either through
RT-PCR or cDNA library screening. Both clones contain an
insertion of 198 bp at position 1211 bp of mice that interrupts the
ORF. Furthermore, sPer3a has two deletions, the prominent one
is 432 bp in length starting at position 1478 bp of the mouse
sequence. At the starting point of this deletion in sPer3a, sPer3b
has a cluster of termination codons at any of the three reading
frames. The apparent initiation ATG is located immediately
after the deletion in the sPer3a or these termination codons in
sPer3b. Omitting the changes in the sPer3b clone yielded a Spalax
Per3 ORF, which is similar to that of mice and humans. It should
be emphasized that similar products have never been obtained
in negative control amplifications with templates generated
without reverse transcriptase enzyme, eliminating the possibility
of genomic DNA contamination. Furthermore, the sPer3 clones
that were isolated from the Spalax brain cDNA library contain
a shorter 3 untranslated region than those of mice and humans,
and in contrast to them, contain an adenylation site 940 bp 3 to
the termination TAA codon. The published 3 untranslated
regions of mice (1,164 bp) and humans (2,421 bp) do not reach
the adenylation site. Southern blot analyses suggest that the
Spalax sPer3 is probably a pseudogene (results not shown).
The nucleotide distances between Spalax Per3 and that of mice
or humans are similar. The protein distances (Fig. 1 Bottom)
between the two Spalax PER3 and mice or humans were 56.21 vs.
57.20 for sPER3a, respectively and 60.41 vs. 57.74 for sPER3b,
respectively. Kimura’s two-parameter nucleotide distance analysis
(33) gave more than two substitutions per bp. Thus, the exact
calculated value is meaningless and depends heavily on the assump-
tions of the correction factors. Nevertheless, the calculated distance
of Spalax vs. mice is even larger than the calculated distance of
Spalax vs. humans. The same is true for the distances calculated
separately for synonymous and nonsynonymous substitutions.
Synonymous vs. Nonsynonymous Substitutions in the Per Family. Our
calculations show that Per2 has a ratio around 0.2, indicating that
it attained optimum function before the divergence of the
species. Per1 and Per3 have a ratio of 0.43 to 0.75, a relatively high
ratio suggesting adaptive evolution. The Drosophila Per showed
a ratio1.0, indicating positive selection for a functional change.
sPer Genes Oscillate in the Spalax SCN. ISH with antisense ribo-
probes in the brain revealed a rhythmic pattern of expression for
sPer1 and sPer2, mainly in the SCN but sPer3 is widely spread in
the brain (Fig. 2). Maximal expression for sPer1 was at ZT6 and
for sPer2 and sPer3 at ZT12. The amplitude of sPer3 expression
was markedly lower (P  0.05) than that of sPer1 and sPer2. The
sense (control) riboprobes of the three sPer had a reproducible
background hybridization that did not overlap with the antisense
probe. No rhythmic expression with the sense riboprobe hybrid-
ization intensity was noted.
sPer Genes Exhibit a Diurnal Oscillation in Spalax Peripheral Tissues.
Significant expression of the three sPer genes was noted, using
RT-PCR, in lung, intestine, liver, harderian gland, eye, brain, and
skeletal muscle (data not shown).
Fig. 1. Similarity tree of the three Per-deduced proteins. The unrooted tree
depicts the similarity relationships of the three PER proteins (amino acids) in
Spalax, mice, rats, humans, and Drosophila.
Fig. 2. Diurnal expression of sPer1, sPer2, and sPer3 of Spalax in the SCN:
coronal sections through the brain. Blue color represents Hoechst-stained nuclei.
(Top) The yellow signal shows the expression of Spalax Per1 over 24 h measured
at 6-h time intervals (ZT0: lights on; ZT12: lights off). Maximal expression is seen
at ZT6. (Middle) The red signal shows the expression of sPer2 in representative
sections. Maximal expression is seen at ZT12. (Bottom) The green signal shows the
expressionof sPer3 inrepresentativesections.Maximalexpression isatZT12.Note
that sPer1 and sPer2 expression is mainly in the SCN, whereas sPer3 expression is
weaker and spreads in different areas of the brain. (Magnification:20.)
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The Spalax Eye. In the Spalax eye (Fig. 3A) ISH revealed a shift
of 6 h in the expression maxima of all three Per genes compared
with the expression in the SCN. Expression of sPer1 was maximal
at ZT12 and of sPer2 and sPer3 at ZT18, but for sPer3, the
amplitude of expression was very small. Thus the RNA rhythms
for all three Per genes of Spalax are present in the photoperiodic
retina, the site of light detection.
The Spalax Harderian Gland. Expression maxima in the harderian
gland could be observed by quantitative RT-PCR (Fig. 3B) and
ISH (data not shown) at the following ZTs: sPer1 at ZT6 and
sPer2 and sPer3 at ZT12. Quantitative RT-PCR analysis in the
liver (Fig. 3B) revealed rhythmic expression of sPer genes with
maxima of sPer1 at ZT12 and of sPer2 and sPer3 at ZT18. The
oscillation in the Spalax liver, as in its eye, shows a 6-h delay
compared with the Spalax SCN. However, the circadian rhythm
in the Spalax harderian gland is synchronous with the expression
pattern in the Spalax SCN.
The Circadian Oscillation of sPer Genes Is Maintained in Constant
Darkness. sPer gene RNA levels in the SCN, eye, and harderian
gland were studied at four time points over a 24-h period, on the
second day in constant darkness (not shown). ISH revealed that
RNA levels of all three sPer genes were rhythmic and the oscillation
pattern under constant darkness was similar to that under 12-h
light12-h dark conditions. Highest levels were observed during the
subjective day in the SCN at circadian time 6 for sPer1 and circadian
time 12 for sPer2 and sPer3. The peak levels of mRNA in the eye
were 6 h later than in the SCN, but were synchronized with the SCN
in the harderian gland. The amplitude of sPer3 rhythmicity was
markedly lower than that of sPer1 and sPer2 in all three tissues
studied and only nearly significant (P  0.05).
Differential Light Regulation of Spalax Per Genes. Previous studies
have shown that mPer1 and mPer2 expression in the SCN is
induced by exposure to light at night (39, 40), whereas mPer3 is
unaffected (41). We examined inducibility of the sPer genes in
the SCN, eye, and harderian gland by nocturnal light pulses at
ZT14 and ZT22 (Fig. 4). These time points were chosen for study
as light pulses at these times produce phase delays and advances
in locomotor activity.
Quantitation of the in situ results showed that 1 h after a light
pulse at ZT14, sPer1 and sPer2 were significantly induced in all
three tissues. Remarkably, the level of sPer1 induction in the
harderian gland was significantly (P  0.05) higher than in the
SCN or the eye, reinforcing its great importance for the Spalax
clock. One hour after the light pulse at ZT22 only sPer1 was
significantly induced in the three tissues examined. Like the
sClock gene, sPer3 gene was not light inducible either at ZT14 or
ZT22 in the three tissues tested.
Discussion
Adaptive Selection on Per Genes in Spalax to Life Underground in
Total Darkness. Like other mammals, the subterranean blind
Spalax has three Per genes.
The distances between sPer1 and sPer2 and those of other
rodents or humans are as expected from their divergence time,
which is estimated to be 40 million years ago and 80 million years
ago, respectively (6). The distances between Spalax or mice and
humans are similar, as expected. Generally, the distances cal-
culated for Per2 are larger than the distances for Per1. In our
analysis of synonymous vs. nonsynonymous substitutions we
relied on Liberles et al. (42), who suggested using this ratio to
reveal selection for change in enzymatic function. Data of
Makalowski and Boguski (43) show that most rodents and
human sequences have a ratio of 0.2. This finding indicates that
such proteins, selected over millions of years, attained an
optimum function before the divergence of rodents and primates
and subsequent evolution was relatively conservative. They also
considered ratios between 0.6 and 1.0 as suggesting a relaxation
of functional constraint and selection. Our results show that
sPer1 and sPer3 have a ratio of 0.4 to 0.6 and sPer2 has a ratio
of about 0.2. Hence, presumably, sPer2 has not been changed to
Fig. 3. Expression of Spalax Per genes in peripheral tissues. (A) Densitometric
analysis of silver grain in situ staining in the eye. The maximal expression in the
eye shows that the expression of the three sPer genes is shifted by 6 h as
compared with their expression in the SCN (Fig. 2). The oscillation of sPer3 is
very weak (P  0.05). (B) Expression of the three sPER genes in the harderian
gland and liver quantitated by RT-PCR. The expression peaks of all three sPer
genes in the harderian gland are synchronized with the SCN (see Fig. 2),
whereas the peak of expression in the liver is shifted by 6 h. As in the SCN, the
difference in sPer3 expression in ZT6 and ZT12 is very small (P  0.05).







function in a visually blind mammal living in a dark environment
with negligible light cues. However, the figures obtained for
sPer1 and sPer3 may suggest that molecular changes in these
genes were necessary to fulfill their expected adaptive function
in darkness. If we combine the calculated distances and the high
ratio of nonsynonymous substitutions, the result supports the
hypothesis of adaptive changes caused by natural selection,
possibly in response to life in darkness underground.
sPer3 evinces a different situation. First, this locus in Spalax
underwent major changes of deletions and insertions, resulting in
two isoforms exhibiting truncated coding regions; somewhat similar
results were reported for the hPer4 pseudogene (44). However,
sPer3 is very different from hPer4. Its insertion could not be
identified with any known sequence, in contrast to the fossil MER-2
mobile element that is within the hPer4 locus (44). When the
changes in the sPer3 are omitted, an ORF similar to mPer3 is
obtained. When the distances were calculated from the aligned
shortened sequences the phylogenetic expectations were not met.
The distances between sPer3 and mPer3 are similar or even larger
than the distances between sPer3 and hPer3. This finding may
support adaptive selective changes in the evolution of this gene and
not just the neutral accumulation of substitutions over time. The
comparison of sPer3 expression patterns with sPer1 and sPer2, which
was described here and is discussed below, raises questions as to the
role that sPer3 plays in the Spalax circadian system.
The Functional Circadian Domains of Spalax Per Genes. sPer1 and
sPer2 contain all functionally relevant domains discovered in other
mammalian PER proteins so far. The basic helix–loop–helix motif
as well as the PAS domain consisting of PAS A, PAS B (39, 45), and
PAC CK1 binding and phosphorylation sites (38) are conserved,
suggesting their role as a CK1 substrate in the central mechanism
of the Spalax circadian clockwork. Remarkably, the whole putative
CK1 binding site as well as the N-terminal basic helix–loop–helix
motif are missing in sPer3. This finding supports a speculation about
its role in the biological clock (45).
Because Spalax is visually blind and lives entirely underground,
hence denied outside Zeitgeber information (6), a robust and
precise internal clock is necessary for the animal to keep track of
time under negligible light cues. Indeed, in situ data revealed that
Spalax Per genes’ expression is clearly rhythmic and maintained
under constant conditions and in constant darkness. sPer1 and sPer2
expression in the Spalax brain is concentrated mainly in the SCN.
However sPer3 is widely spread in different areas of the brain,
similar to what has been reported for the mouse Per3 (41), and its
oscillation levels are less prominent than those of sPer1 and sPer2.
These findings raise a question as to the role of Per3 in the circadian
system. The central pacemaker of the SCN signals time to the retina
and peripheral clocks, as in the liver, where the circadian genes’
expression follows its rhythm with a delay of 4–6 h (41, 46). The
blind Spalax Per genes’ expression is similar, and our results also
show a lag of 6 h in the peak expression of the Per genes in the retina
and liver. Although the exact role of Spalax Per3 in the maintenance
of the circadian rhythm remains unresolved, it may prove substan-
tial for time keeping underground.
The Harderian Gland: A Circadian Center in Spalax. Noteworthy,
mRNA levels in the Spalax hypertrophic harderian gland oscillate
synchronously with the SCN. Similar synchronization in the peak
levels of mRNA in the SCN and the harderian gland was seen also
for Spalax MOP3 gene (8), the dimerization partner of the CLOCK
protein (47) and an essential component of the circadian pace-
maker in mammals (48). Furthermore, sPer1 inducibility in the
harderian gland after light pulse during the dark phase of the clock
cycle is much higher than in the SCN. The harderian gland of Spalax
is extraordinarily enlarged and occupies the entire eye socket,
presumably as an adaptation to life underground. Previous studies
(15) suggested that the harderian gland of Spalax is a possible
photoreceptor and photoperiodic organ. Given its exposed position
directly behind the atrophied minute eye, it seems likely that the
harderian gland has a prominent role in the Spalax clock mecha-
nism. This gland may demonstrate the extreme of evolutionary
progression during the adaptive morphological and molecular
reorganization for life underground (6).
Differential Regulation of Spalax Per Genes. Light inducible exper-
iments in Spalax reveal that sPer1 is light inducible both early
(ZT14) and late (ZT22) at night, whereas sPer2 is light inducible
only at the beginning of the night. This result is in accordance with
the findings of Albrecht et al. (39). sPer3 levels are unresponsive to
light pulses applied throughout the dark phase of the circadian
cycle. This differential regulation among the three sPer genes
suggests that each has a different regulatory function in the SCN.
The behavioral effects of photic stimuli at these two time points
(ZT14 and ZT22) have been characterized in mice (49, 50). Light
pulse at ZT14 causes phase delays in behavioral rhythms and light
pulse at ZT22 causes phase advances. Our results indicate a role of
sPer1 in both phases and of sPer2 in the phase-delay mechanism.
Our in situ data provide a molecular confirmation of previous
Fig. 4. Light inducibility of the three Spalax Per genes’ expression. Animals
were given a 15-min light pulse at ZT14 and ZT22 and killed 1 h later. Coronal
sections through the brain and ISH were performed on treated (ZT14 pulse and
ZT22 pulse) and control animals that were killed at the same time. Relative
mRNA induction was analyzed by densitometric analysis of in situ silver grain
staining. sClock inducibility is given as negative control. (Top) In the SCN, sPer1
is equally inducible at ZT14 and ZT22. sPer2 is inducible only at ZT14, whereas
sPer3 gene shows no measurable changes in expression levels at the two time
points. (Middle) Inducibility of sPer1, sPer2, and sPer3 in the eye is similar to
that in the SCN. (Lower) In the harderian gland, sPer1 is highly inducible at
ZT14 and less at ZT22 whereas sPer2 expression is light sensitive only at ZT14.
sPer3 shows no light inducibility at either time point. Note the significantly
(P 0.01) higher induction of sPer1 in the harderian gland compared with the
other tissues after light pulse at ZT14. Note the different y-axis scales in SCN,
eye, and harderian.
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behavioral studies in Spalax (11) and link the activity pattern of
these species with the cellular cycling in sighted animals. The poor
sPer3 oscillation and the absence of light influence on sPer3
expression levels may suggest a role for sPer3 outside the central
pacemaker. This finding is consistent with data from Per3-deficient
mice (51, 52) but may prove an adaptation to life underground and
deserves further critical studies.
All three Spalax Per genes are expressed in a wide variety of
nonneural tissues as previously shown in Drosophila (53, 54) and
mice (39, 41). In three of these tissues (liver, eye, and harderian
gland) we found that the RNA levels for the three sPer genes
oscillate. Oscillation of sPer genes in the eye, the target organ of
light absorption, is rational. As we already suggested, the oscil-
lation of the sPer genes in the Spalax harderian gland is in
accordance with previous results, suggesting an important role of
this tissue in circadian maintenance (15) and merits further
intensive study. The oscillation in the liver and the widespread
expression in other peripheral tissues that were examined suggest
the existence of clocks outside the SCN.
Molecular-Genetic Tinkering of Circadian Genes in a Blind Mammal. This
study substantiates the claim that the blind subterranean Spalax
needs a photoperiodic system to perceive daily and seasonal cycles.
It has retained a functional retina with effective visual pigment
genes signaling to the SCN (14, 17–20, 23, 24) presumably induced
by the small amount of photons that penetrate underground to an
otherwise dark environment. Circadian genes in the retina, hard-
erian gland, SCN, and other tissues, including Clock (8) and the
three Per genes described here, process the light signals and
translate them into the unique behavioral repertoire of Spalax,
including polyphasic, polymorphic, and seasonal behavioral phe-
notypes. In this respect we should emphasize that Spalax exhibits
naturally occurring predominantly either diurnal or nocturnal in-
dividuals. Currently we are studying the expression pattern of the
Per genes in naturally occurring nocturnal animals or on diurnal
animals after a phase shift of light. The mosaic evolution of the
Spalax eye (17, 18), harderian gland (30), and brain (26–28) and its
circadian genes provide a striking model of tinkering evolution at
both the molecular and organismal levels. From an evolutionary
perspective the genetic basis of circadian rhythms in the blind
subterranean Spalax may be different from that of strictly diurnal
or nocturnal and sighted mammals. Identification of the circadian
genes of blind Spalax might advance insights into the structure and
evolution of the circadian organization in mammals, including
humans, at the molecular level and their ecological causation.
Remarkably, the colonization of the subterranean dark ecological
zone by Spalax did not obliterate the conservative circadian rhyth-
micity and its genetic basis of photoreceptiveness and clock genes.
All of the circadian machinery was adaptively transformed to
perceive light in darkness.
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